For research teamsHelp me find a study
Back to all studies
Not Yet RecruitingNCT07419009

Feasibility of Modulating Cognitive Control in OCD

This study is not yet recruiting. It focuses on mental health and currently lists study information in Global.

Mental health, Obsessive-Compulsive Disorder (OCD)OtherFrom 18 Years to 60 Years
Need help deciding?

Ask HopeStage to review this study with me

Loading the security check...
Study ID: NCT07419009. We help you review the study, but cannot decide medical eligibility.
In plain English

Key information made simple

This study is looking at care and outcomes for people with Obsessive-Compulsive Disorder. Taking part may give some people access to continuous theta-burst transcranial magnetic stimulation (cTBS), but direct benefit is not guaranteed.

What to expect

Your next step

The official record does not clearly spell out the visit format, but it appears to be coordinated directly by the research team. Participation appears to involve study activities and check-ins designed to see how this approach works in practice. The main fit is usually matching the main diagnosis and being able to understand the study and consent, while common reasons not to take part include active substance or alcohol problems that could affect the results and safety concerns that need urgent care first. The official record does not list a formal phase, which usually means this is focused more on feasibility, delivery, or support than a standard drug-development stage.

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateEstimated: February 15, 2026
Recruitment status
Not Yet Recruiting
Estimated enrollment
Not clearly listed
Sponsor
Dartmouth-Hitchcock Medical Center
Sponsor type
Hospital / academic medical center
Study type
Other
Intervention type
Device / app / digital / technology
Study phase
Not clearly listed
Locations
Global
Age range
From 18 Years to 60 Years
Official registry ID
NCT07419009
Official source
Official registry link

Want help reviewing this study?

Loading the security check...
Study ID: NCT07419009. We help you review the study, but cannot decide medical eligibility.
Public study data

Key study information

Official title
Feasibility of Modulating Cognitive Control in OCD
Condition
Mental health, Obsessive-Compulsive Disorder (OCD)
Study status
Not Yet Recruiting
Sponsor / lead affiliation
Dartmouth-Hitchcock Medical Center
Location / country
Global
Registry
ClinicalTrials.gov
External trial ID
NCT07419009
Why this study may matter

Why this study may matter

This study may matter because it adds public evidence around mental health. HopeStage presents it as a starting point for understanding the study, checking the official source, and preparing questions with a care team.

In practice

For you

Taking part may help improve understanding of your condition.

It requires regular follow-up, often through questionnaires or interviews.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring medication or study treatment for people with mental health. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

Does this study involve a device, app, or technology?

This appears to be a device / app / digital / technology study. The phase is not clearly listed in the public registry. Phase is mostly relevant for medication studies and some device studies. For this study, it may be more useful to look at what is required, the duration, visits, and eligibility criteria.

Do I need to want to stop or reduce tobacco use to participate?

The public registry appears to mention tobacco, nicotine, alcohol, cannabis, or another addiction-related topic. Ask the study team whether you need to want to stop, reduce, already be abstinent, or simply meet use-related criteria. Eligibility must be confirmed by the study team.

What would I likely need to do?

You may need to use a device, app, or digital tool for a defined period. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

What should I check about data, monitoring, alerts, and daily use?

If the study uses a device, app, or digital tool, check what data is collected, who can access it, how often you need to use it, and what happens if the tool detects a concerning signal. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by Dartmouth-Hitchcock Medical Center, which appears to be a hospital or academic medical center. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The registry indicates that this study has not started recruiting yet. You can check the planned start date and available contacts.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me
Related studies

Other studies you may want to explore next